NEW YORK (GenomeWeb) – The US Food and Drug Administration has granted Emergency Use Authorization (EUA) to Nanobiosym's Gene-Radar Zika virus test, the company said today.

According to Nanobiosym, the test is based on its Gene-Radar portable diagnostic platform and can qualitatively detect Zika RNA in human serum from individuals meeting the Centers for Disease Control and Prevention's Zika virus clinical and/or epidemiological criteria.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.